IP Library Granted Patent US 12,685,844
Granted Patent B2
US 12,685,844 · App. 17/767,553 · Granted Jul 21, 2026

Guidewire with elastically articulatable tip

Inventor: Michael Gabriel Tal (Tel Aviv, IL)
Assignee: Embrace Medical Ltd.
A61M25/09A61M25/09041A61M39/0208A61M2025/09175A61M2025/09191A61M2039/0235
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,685,844
App. No.
17/767,553
Filed
Apr 8, 2022
Granted
Jul 21, 2026
Kind
B2
Art Unit
3791
USPC
600/585
Abstract

A guidewire for vascular access has an elastically articulatable tip configured to minimize risk of vessel wall damage during initial insertion of the guidewire into the vasculature of a patient. The guidewire may have a local flexible portion in a tip segment of the guidewire and/or a core thereof.

Claims (46)

1 . A guidewire for transluminal routing of artifacts in a blood vessel, comprising:

a guidewire body comprising an elastic core member extending along at least most of the length of the guidewire body, the guidewire body comprising a guidewire proximal segment, a tip segment and a guidewire intermediate segment extending between the guidewire proximal segment and the tip segment;

wherein resistance to bending of the guidewire intermediate segment along at least most of the length thereof is smaller than resistance to bending along at least most of the length of the guidewire proximal segment;

wherein the tip segment includes a local flexing portion having a resistance to bending smaller than (1) the resistance to bending of the guidewire intermediate segment, (2) of a front portion of the tip segment extending to distally from the local flexing portion, and (3) of a rear portion of the tip segment extending proximally from the local flexing portion, thereby affecting localized elastic articulatability of the front portion of the tip segment relative to the rear portion of the tip segment and/or to the guidewire intermediate segment;

wherein the elastic core member has a diameter that reduces from a first diameter proximal to a narrowing to a second diameter smaller than the first diameter distal to the narrowing; and

wherein the elastic core member comprises a widening proximal to the local flexing portion, wherein the widening increases the elastic core member diameter from a third diameter proximal to the widening to a fourth diameter greater than the third diameter distal to the widening.

2 . The guidewire according to claim 1 , wherein the local flexing portion is configured to facilitate and cause elastically recoverable buckling of the rear portion of the tip segment upon longitudinal compression of the guidewire body against a blood vessel wall, when the front portion of the tip segment is forcefully articulated relative to the rear portion of the tip segment.

3 . The guidewire according to claim 1 , wherein the tip segment is 20 mm or less in total length.

4 . The guidewire according to claim 1 , wherein the tip segment is 10 mm or less in total length.

5 . The guidewire according to claim 1 , wherein the tip segment is 5 mm or less in total length.

6 . The guidewire according to claim 1 , wherein the local flexing portion includes at least one of a slit, a joint, an indentation, a coiled segment, or any combination thereof.

7 . The guidewire according to claim 1 , wherein the third core member diameter is equal to or smaller than the second core member diameter and/or the fourth core member diameter is equal to the first core member diameter.

8 . The guidewire according to claim 1 , wherein the elastic core member is embedded in a matrix of flexible material between the narrowing and the widening of the elastic core member, such that an overall diameter of the guidewire body along at least most of the length of the guidewire intermediate segment is equal to the first diameter.

9 . The guidewire according to claim 1 , wherein the elastic core member is covered with a cylindrical coiled member between the narrowing and the widening of the elastic core member, such that an overall diameter of the guidewire body along at least most of the length of the guidewire intermediate segment is equal to the first diameter.

10 . The guidewire according to claim 9 , wherein the cylindrical coiled member is formed of a spring or elastic metal alloy and is fixated to the elastic core member at or adjacent to the narrowing or at or adjacent to the widening.

11 . The guidewire according to claim 1 , wherein the core member incorporates the flexing portion along the tip segment.

12 . The guidewire according to claim 1 , wherein the local flexing portion has a length along the guidewire body that is equal to or smaller than 5 mm.

13 . The guidewire according to claim 1 , wherein the local flexing portion has a length along the guidewire body of equal to or smaller than 3 mm.

14 . The guidewire according to claim 1 , wherein the local flexing portion is equal to or smaller than 1 mm.

15 . The guidewire according to claim 1 , wherein the elastic core member is formed of a selectively heat-treated shape memory alloy.

16 . The guidewire according to claim 15 , wherein a portion of the elastic core member is heat-treated by exposure to a temperature of about 500° C. or less during a period of about 1 minute or less.

17 . The guidewire according to claim 16 , wherein the exposure precedes fixation of a distal end of a coiled member to the elastic core member distally to the local flexing portion.

18 . The guidewire according to claim 1 , wherein the resistance to bending of the local flexing portion increases when an angle formed between the front portion of the tip segment and the rear portion of the tip segment reduces.

19 . The guidewire according to claim 18 , wherein a minimally allowed articulation angle between the front portion of the tip segment and the rear portion of the tip segment is between 150° and 90°.

20 . The guidewire according to claim 19 , wherein the minimally allowed articulation angle is between 135° and 95°.

21 . The guidewire according to claim 1 , wherein a total length of the local flexing portion is 0.5 mm or less.

22 . The guidewire according to claim 1 , wherein a diameter of the local flexing portion is equal to a diameter of the rear portion of the tip segment and/or to the guidewire intermediate segment.

23 . The guidewire according to claim 1 , wherein a center of the local flexing portion is 5 mm or less from a distal end of the guidewire body.

24 . The guidewire according to claim 1 , wherein a center of the local flexing portion is 1 mm or less from a distal end of the guidewire body.

25 . A kit comprising:

a guidewire comprising a guidewire body having a guidewire proximal segment, a tip segment and a guidewire intermediate segment extending between the guidewire proximal segment and the tip segment; and

a needle comprising a beveled opening distally adjacent to a distal needle tip;

wherein resistance to bending of the guidewire intermediate segment along at least most of the length thereof is smaller than resistance to bending along at least most of the length of the guidewire proximal segment;

wherein the tip segment includes a local flexing portion having resistance to bending smaller than (1) the resistance to bending of the guidewire intermediate segment, (2) of a front portion of the tip segment extending to distally from the local flexing portion, and (3) of a rear portion of the tip segment extending proximally from the local flexing portion, thereby affecting localized elastic articulatability of the front portion of the tip segment relative to the rear portion of the tip segment and/or to the guidewire intermediate segment;

wherein the beveled opening has a length configured such that when the front portion of the tip segment is pushed against a blood vessel wall, the front portion is configured to articulate about the local flexing portion upon axial protrusion from the beveled opening.

26 . The kit according to claim 25 , wherein the beveled opening is equal to or greater by up to 2 mm than the front portion in length.

27 . The kit according to claim 25 , wherein the beveled opening is equal to or smaller by up to 2 mm than the front portion in length.

28 . A guidewire for transluminal routing of artifacts in a blood vessel, comprising:

a guidewire body comprising a guidewire proximal segment, a tip segment and a guidewire intermediate segment extending between the guidewire proximal segment and the tip segment;

wherein resistance to bending of the guidewire intermediate segment along at least most of the length thereof is smaller than resistance to bending along at least most of the length of the guidewire proximal segment;

wherein the tip segment includes a local flexing portion having resistance to bending smaller than the resistance to bending of (1) the guidewire intermediate segment, (2) of a front portion of the tip segment extending to distally from the local flexing portion, and (3) of a rear portion of the tip segment extending proximally from the local flexing portion, thereby affecting localized elastic articulatability of the front portion of the tip segment relative to the rear portion of the tip segment and/or to the guidewire intermediate segment;

wherein the resistance to bending of the local flexing portion is smaller than resistance to penetration of a wall of the blood vessel with the tip segment when the front portion of the tip segment and the rear portion of the tip segment are aligned, and/or

wherein the resistance to bending of the local flexing portion is greater than a resistance to buckling of the rear portion of the tip segment when the front and the rear portions of the tip segment form a minimally allowed articulation angle therebetween.

29 . The guidewire according to claim 28 , wherein the local flexing portion is about 3 mm or less in length and distant about 5 mm or less from a distal end of the guidewire body.

30 . The guidewire according to claim 28 , wherein the resistance to bending of the local flexing portion is smaller than resistance to penetration of a wall of the blood vessel with the tip segment when the front portion of the tip segment and the rear portion of the tip segment are aligned.

31 . The guidewire according to claim 29 , wherein the resistance to bending of the local flexing portion is greater than a resistance to buckling of the rear portion of the tip segment when the front and the rear portions of the tip segment form a minimally allowed articulation angle therebetween.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2022
From: TAL, MICHAEL GABRIEL
To: EMBRACE MEDICAL LTD.
Reel/Frame 059542/0290 →
Continuity (2)
Provisional Application 62915973 · Oct 16, 2019
Related Publication 20220401706A1 · Dec 22, 2022
References Cited (109)
US 1879249A · Coy · 1932 [cited by applicant]
US 2717599A · Jennie · 1955 [cited by applicant]
US 2746454A · Sorensen · 1956 [cited by applicant]
US 3521620A · Cook · 1970 [cited by applicant]
US 4456017A · Miles · 1984 [cited by applicant]
US 4661300A · Daugherty · 1987 [cited by applicant]
US 4716757A · McGregor et al. · 1988 [cited by applicant]
US 4904433A · Williamitis · 1990 [cited by applicant]
US 4919605A · Kousai et al. · 1990 [cited by applicant]
US 5057083A · Gellman · 1991 [cited by applicant]
US 5102324A · Bullard et al. · 1992 [cited by applicant]
US 5111829A · Alvarez de Toledo · 1992 [cited by examiner]
US 5341818A · Abrams et al. · 1994 [cited by applicant]
US 5352205A · Dales et al. · 1994 [cited by applicant]
US 5365942A · Shank · 1994 [cited by applicant]
US 5478328A · Silverman et al. · 1995 [cited by applicant]
US 5484565A · Larsen et al. · 1996 [cited by applicant]
US 5497786A · Urick · 1996 [cited by applicant]
US 5531701A · Luther · 1996 [cited by applicant]
US 5716572A · Lesiczka et al. · 1998 [cited by applicant]
US 5807279A · Viera · 1998 [cited by applicant]
US 5843356A · Patel et al. · 1998 [cited by applicant]
US 5857464A · Desai · 1999 [cited by applicant]
US 5865767A · Frechette et al. · 1999 [cited by applicant]
US 5957865A · Backman et al. · 1999 [cited by applicant]
US 5985195A · Muskatello · 1999 [cited by applicant]
US RE36628E · Sagae et al. · 2000 [cited by applicant]
US 6113557A · Fagan et al. · 2000 [cited by applicant]
US 6596011B2 · Johnson et al. · 2003 [cited by applicant]
US 6638266B2 · Wilson et al. · 2003 [cited by applicant]
US 6740277B2 · Howell et al. · 2004 [cited by applicant]
US 6979318B1 · McDonald et al. · 2005 [cited by applicant]
US 7029467B2 · Currier et al. · 2006 [cited by applicant]
US 7762962B2 · Mishima · 2010 [cited by applicant]
US 7959595B2 · Melsheimer et al. · 2011 [cited by applicant]
US 8092395B2 · Lupton et al. · 2012 [cited by applicant]
US 8142416B2 · Stauber · 2012 [cited by applicant]
US 8936581B2 · Bihlmaier · 2015 [cited by applicant]
US 8986225B2 · Folk · 2015 [cited by applicant]
US 9078994B2 · Rosenman et al. · 2015 [cited by applicant]
US 9757536B2 · Abt et al. · 2017 [cited by applicant]
US 9987423B2 · Kuracina et al. · 2018 [cited by applicant]
US 9987468B2 · Bagwell et al. · 2018 [cited by applicant]
US 10384039B2 · Ribelin et al. · 2019 [cited by applicant]
US 10441746B2 · Besselink · 2019 [cited by applicant]
US 10478592B2 · Shevgoor · 2019 [cited by applicant]
US 10610668B2 · Burkholz et al. · 2020 [cited by applicant]
US 10820923B2 · Govari · 2020 [cited by applicant]
US 10987489B2 · Von Segesser · 2021 [cited by applicant]
US 20020082523A1 · Kinsella et al. · 2002 [cited by applicant]
US 20030163064A1 · Vrba et al. · 2003 [cited by applicant]
US 20040167436A1 · Reynolds et al. · 2004 [cited by applicant]
US 20040167437A1 · Sharrow et al. · 2004 [cited by applicant]
US 20050049690A1 · Boismier et al. · 2005 [cited by applicant]
US 20080281156A1 · Makower · 2008 [cited by examiner]
US 20090076435A1 · Melsheimer et al. · 2009 [cited by applicant]
US 20100217234A1 · Grovender et al. · 2010 [cited by applicant]
US 20120065569A1 · Steegers et al. · 2012 [cited by applicant]
US 20140163420A1 · Kosugi · 2014 [cited by applicant]
US 20150038908A1 · Antonucci · 2015 [cited by applicant]
US 20160256667A1 · Ribelin et al. · 2016 [cited by applicant]
US 20170259041A1 · Lenker · 2017 [cited by applicant]
US 20190030290A1 · Ginster · 2019 [cited by applicant]
US 20190038876A1 · Isaacson et al. · 2019 [cited by applicant]
US 20190038877A1 · Isaacson et al. · 2019 [cited by applicant]
US 20200188632A1 · Burkholz et al. · 2020 [cited by applicant]
US 20200330729A1 · Petitpierre et al. · 2020 [cited by applicant]
US 20220211981A1 · Darbellay et al. · 2022 [cited by applicant]
US 20220401706A1 · Tal · 2022 [cited by applicant]
US 20230398331A1 · Tal · 2023 [cited by applicant]
CN 103845785A · 2014 [cited by applicant]
CN 116615266A · 2023 [cited by applicant]
IN 202227020741A · 2022 [cited by applicant]
JP H04108555A · 1992 [cited by applicant]
JP 2005169012A · 2005 [cited by applicant]
JP 2006055674A · 2006 [cited by applicant]
JP 2012205800A · 2012 [cited by applicant]
JP 2014113177A · 2014 [cited by applicant]
JP 2012205800B · 2015 [cited by applicant]
JP 2016002210A · 2016 [cited by applicant]
JP 2018519015A · 2018 [cited by applicant]
JP 2019111083A · 2019 [cited by applicant]
JP 2019150439A · 2019 [cited by applicant]
WO 2009131583A1 · 2009 [cited by applicant]
WO 2010110132A1 · 2010 [cited by applicant]
WO 2014162389A1 · 2014 [cited by applicant]
WO 2019081962A1 · 2019 [cited by applicant]
WO 2021076894A1 · 2021 [cited by applicant]
WO 2022081201A1 · 2022 [cited by applicant]
Decision of Rejection mailed on Dec. 4, 2024 in JP 2022-520864. [cited by applicant]
Extended European Search Report mailed on Jan. 10, 2025 in EP 21880704.8. [cited by applicant]
Notice of Allowance mailed on Feb. 18, 2025 in CA 3156632. [cited by applicant]
Office Action mailed on Jan. 27, 2025 in JP 2023-523198. [cited by applicant]
Partial Supplementary European Search Report mailed on Oct. 14, 2024 in EP 21880704.8. [cited by applicant]
Supplementary European Search Report mailed on Jan. 28, 2025 in EP 21880704.8. [cited by applicant]
International Search Report and Written Opinion mailed Feb. 9, 2021 in PCT/US2020/055991. [cited by applicant]
International Search Report and Written Opinion mailed Sep. 14, 2021 in PCT/US2021/027280. [cited by applicant]
Extended European Search Report mailed on Feb. 15, 2024 in EP 21753965.9. [cited by applicant]
Final Office Action mailed on May 1, 2024 in JP 2022-520864. [cited by applicant]
International Preliminary Report on Patentability received for WO Patent Application Serial No. PCTUS2021027280 dated Apr. 27, 2023, 10 pages. [cited by applicant]
International Search Report and Written Opinion mailed on Sep. 14, 2021 in PCT/US2021/027280. [cited by applicant]
Invitation to Pay Additional Fees mailed Nov. 25, 2020 in International Patent Application No. PCT/US2020/055991. [cited by applicant]
Office Action mailed on Apr. 3, 2024 in CA 3156632. [cited by applicant]
Communication pursuant to Article 94(3) EPC mailed on Dec. 15, 2025 in EP 20876438.1. [cited by applicant]
Examination Report mailed on Apr. 2, 2025 in AU 2020368478. [cited by applicant]
International Preliminary Report on Patentability, mailed Apr. 13, 2023. [cited by applicant]
Office Action mailed on Aug. 1, 2025 in CN 202180085436.3. [cited by applicant]
Office Action mailed on Aug. 27, 2025 in JP 2023-523198. [cited by applicant]
Supplementary European Search Report mailed Jan. 16, 2024. [cited by applicant]